A review of drug therapy for neonatal hypertension

Michele J. Beaulieu, Christina Carsello

Research output: Contribution to journalArticle

Abstract

Neonatal hypertension is becoming a more common diagnosis because of higher survival rates in premature infants and the need for intravascular access and invasive blood pressure (BP) monitoring. Defining hypertension in the neonatal population has been challenging, and understanding what constitutes a normal BP is still evolving. Five general classes of antihypertensives exist for the treatment of hypertension in neonates. Few studies are available to guide clinicians in the treatment of hypertension in neonates, and limited data exist regarding outcomes of hypertension in the neonatal period.

Original languageEnglish (US)
Pages (from-to)95-100
Number of pages6
JournalNeonatal Network
Volume33
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Hypertension
Drug Therapy
Newborn Infant
Blood Pressure
Premature Infants
Antihypertensive Agents
Therapeutics
Population

Keywords

  • Angiotensin-converting enzyme inhibitors (ACEI)
  • Antihypertensives
  • Hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care
  • Critical Care and Intensive Care Medicine

Cite this

A review of drug therapy for neonatal hypertension. / Beaulieu, Michele J.; Carsello, Christina.

In: Neonatal Network, Vol. 33, No. 2, 2014, p. 95-100.

Research output: Contribution to journalArticle

Beaulieu, Michele J. ; Carsello, Christina. / A review of drug therapy for neonatal hypertension. In: Neonatal Network. 2014 ; Vol. 33, No. 2. pp. 95-100.
@article{42a457830c564bdb953a68a4438ca078,
title = "A review of drug therapy for neonatal hypertension",
abstract = "Neonatal hypertension is becoming a more common diagnosis because of higher survival rates in premature infants and the need for intravascular access and invasive blood pressure (BP) monitoring. Defining hypertension in the neonatal population has been challenging, and understanding what constitutes a normal BP is still evolving. Five general classes of antihypertensives exist for the treatment of hypertension in neonates. Few studies are available to guide clinicians in the treatment of hypertension in neonates, and limited data exist regarding outcomes of hypertension in the neonatal period.",
keywords = "Angiotensin-converting enzyme inhibitors (ACEI), Antihypertensives, Hypertension",
author = "Beaulieu, {Michele J.} and Christina Carsello",
year = "2014",
doi = "10.1891/0730-0832.33.2.95",
language = "English (US)",
volume = "33",
pages = "95--100",
journal = "Neonatal network : NN",
issn = "0730-0832",
publisher = "Neonatal Network",
number = "2",

}

TY - JOUR

T1 - A review of drug therapy for neonatal hypertension

AU - Beaulieu, Michele J.

AU - Carsello, Christina

PY - 2014

Y1 - 2014

N2 - Neonatal hypertension is becoming a more common diagnosis because of higher survival rates in premature infants and the need for intravascular access and invasive blood pressure (BP) monitoring. Defining hypertension in the neonatal population has been challenging, and understanding what constitutes a normal BP is still evolving. Five general classes of antihypertensives exist for the treatment of hypertension in neonates. Few studies are available to guide clinicians in the treatment of hypertension in neonates, and limited data exist regarding outcomes of hypertension in the neonatal period.

AB - Neonatal hypertension is becoming a more common diagnosis because of higher survival rates in premature infants and the need for intravascular access and invasive blood pressure (BP) monitoring. Defining hypertension in the neonatal population has been challenging, and understanding what constitutes a normal BP is still evolving. Five general classes of antihypertensives exist for the treatment of hypertension in neonates. Few studies are available to guide clinicians in the treatment of hypertension in neonates, and limited data exist regarding outcomes of hypertension in the neonatal period.

KW - Angiotensin-converting enzyme inhibitors (ACEI)

KW - Antihypertensives

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=84894535634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894535634&partnerID=8YFLogxK

U2 - 10.1891/0730-0832.33.2.95

DO - 10.1891/0730-0832.33.2.95

M3 - Article

C2 - 24589901

AN - SCOPUS:84894535634

VL - 33

SP - 95

EP - 100

JO - Neonatal network : NN

JF - Neonatal network : NN

SN - 0730-0832

IS - 2

ER -